The North American Cystic Fibrosis Conference (NACFC) is the largest annual conference sharing new scientific knowledge and best practices in the field of cystic fibrosis (CF). This year, the 2020 NACFC is being held virtually due to the COVID-19 pandemic, with live streaming sessions from October 20-23.
As the needs for remote monitoring of lung health grow for patients with respiratory conditions, many providers and patients seek to better understand the quality of home tests versus tests that are traditionally performed at the hospital with clinical supervision.
A poster presented today at NACFC shares results from a Royal Brompton & Harefield NHS Trust study evaluating the quality of unsupervised home spirometry vs. supervised spirometry at the hospital using the NuvoAir platform.
Results from 37 adult patients with CF, over a period of nearly a year, show that unsupervised home spirometry was equivalent to spirometry in the clinic setting. NuvoAir includes an in-app coaching feature to support patients with quality results. The study also found high patient adherence to a twice a month spirometry schedule. The full abstract is available here.
These findings show acceptability of the NuvoAir platform for both patients and their providers and largely open up opportunities for long-term remote monitoring of patients as a component of their chronic care management.